Sun Pharmaceutical Industries has launched Tedizolid Phosphate tablets 200 mg in India under the brand name STARIZO. STARIZO (Tedizolid Phosphate) is a novel, oxazolidinone-class antibacterial, used to treat Acute Bacterial Skin and Skin Structure Infection (ABSSSI).
Sun Pharma has obtained rights from Merck Sharp & Dohme Singapore Trading to develop, manufacture and commercialise Tedizolid Phosphate in India.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Media Majors, stock market, share market, stock trading")
 "Monkeypox")
 "Sun Pharma")
 "Doctor Protest, Protest, Kolkata Doctor Protest")
 "Air India")
